Razavi, Z., Maher, S. and Fredmal, J. (2018) Comparison of Subcutaneous Insulin Aspart and Intravenous Regular Insulin for the Treatment of Mild and Moderate Diabetic Ketoacidosis in Pediatric Patients. Endocrine, 61, 267-274.
https://doi.org/10.1007/s12020-018-1635-z

has been cited by the following article:

• TITLE: Proposed Libyan Guidelines for the Management of Inpatient Hyperglycemia with Corona Virus-19 (COVID-19) Infection

  AUTHORS: Adela H. Elamami

  KEYWORDS: In-Patient Hyperglycemia, COVID-19, Management, Proposed Guideline, Libya

  JOURNAL NAME: Open Journal of Epidemiology, Vol.11 No.3, July 23, 2021

  ABSTRACT: Serious hyperglycemia is one of the manifestations of COVID-19 infection which increase patient morbidity and mortality especially in patient requiring hospitalization. Consequently, many protocols and algorithms for hospitalized patients with COVID-19 induced hyperglycemia based mainly on recent studies and previous evidence on non-COVID-19 patients were published. Of note nearly all guidelines released by the different COVID-19 committees in Libya don’t include a clear focus on management of in-patient hyperglycemia and maybe this plays a pivotal role in increase our COVID-19 in-hospital mortality. I proposed a simplified approach depending on the released international guidelines to be easily implemented by Libyan health care staff caring about COVID-19 patients and hoping to be accepted by our National Diabetes Committee.